- Home
- FRD vs NKTR Comparison
FRD vs NKTR Comparison
Compare FRD & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRD
- NKTR
- Stock Information
- Founded
- FRD 1965
- NKTR 1990
- Country
- FRD United States
- NKTR United States
- Employees
- FRD N/A
- NKTR N/A
- Industry
- FRD Steel/Iron Ore
- NKTR Biotechnology: Pharmaceutical Preparations
- Sector
- FRD Industrials
- NKTR Health Care
- Exchange
- FRD Nasdaq
- NKTR Nasdaq
- Market Cap
- FRD 114.4M
- NKTR 108.3M
- IPO Year
- FRD N/A
- NKTR 1994
- Fundamental
- Price
- FRD $16.50
- NKTR $25.53
- Analyst Decision
- FRD
- NKTR Strong Buy
- Analyst Count
- FRD 0
- NKTR 6
- Target Price
- FRD N/A
- NKTR $77.50
- AVG Volume (30 Days)
- FRD 59.9K
- NKTR 4.5M
- Earning Date
- FRD 06-12-2025
- NKTR 08-07-2025
- Dividend Yield
- FRD 0.97%
- NKTR N/A
- EPS Growth
- FRD N/A
- NKTR N/A
- EPS
- FRD 0.87
- NKTR N/A
- Revenue
- FRD $444,600,000.00
- NKTR $87,248,000.00
- Revenue This Year
- FRD N/A
- NKTR N/A
- Revenue Next Year
- FRD N/A
- NKTR N/A
- P/E Ratio
- FRD $18.93
- NKTR N/A
- Revenue Growth
- FRD N/A
- NKTR N/A
- 52 Week Low
- FRD $12.24
- NKTR $6.48
- 52 Week High
- FRD $19.12
- NKTR $37.38
- Technical
- Relative Strength Index (RSI)
- FRD 50.72
- NKTR 70.35
- Support Level
- FRD $15.65
- NKTR $8.27
- Resistance Level
- FRD $16.75
- NKTR $37.38
- Average True Range (ATR)
- FRD 0.60
- NKTR 3.58
- MACD
- FRD -0.02
- NKTR 1.48
- Stochastic Oscillator
- FRD 52.16
- NKTR 59.68
About FRD Friedman Industries Inc.
Friedman Industries Inc is engaged in the manufacturing and processing of steel products. The company's operating segments include flat-roll products and Tubular Products. It generates maximum revenue from the flat-roll products segment. The company's products and services include Temper Pass, Cut-To-Length, Whole Coils, Toll Processing, Electric Resistance Welded Pipe (ERW), New Mill Secondary, and Pipe Finishing Services.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.